Gender moderates the relationship between testosterone and marital interaction.

Higher testosterone levels are related to assertiveness and dominance. Given the relevance of those behavioral correlates to spouses' daily transactions, links between testosterone levels and marital interaction were explored among 92 newlywed couples. Marital problem-solving and social support transactions were assessed, and saliva was collected and assayed for testosterone. Whether marital behavior was related to husbands' and wives' testosterone levels was examined. The link between spouses' testosterone and their behavior was contingent on the partner's testosterone levels. Husbands exhibited more adaptive problem-solving behaviors and social support provision when husbands and wives were concordant for lower testosterone levels. In contrast, wives exhibited more adaptive support provision when spouses had discordant testosterone levels such that wives had higher levels and husbands had lower levels. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Neuroprotective Effects of Testosterone in the Hypothalamus of an Animal Model of Metabolic Syndrome

Metabolic syndrome (MetS) is known to be associated to inflammation and alteration in the hypothalamus, a brain region implicated in the control of several physiological functions, including energy homeostasis and reproduction. Previous studies demonstrated the beneficial effects of testosterone treatment (TTh) in counteracting some MetS symptoms in both animal models and clinical studies. This study investigated the effect of TTh (30 mg/kg/week for 12 weeks) on the hypothalamus in a high-fat diet (HFD)-induced animal model of MetS, utilizing quantitative RT-PCR and immunohistochemical analyses. The animal model recapitulates the human MetS features, including low testosterone/gonadotropin plasma levels. TTh significantly improved MetS-induced hypertension, visceral adipose tissue accumulation, and glucose homeostasis derangements. Within hypothalamus, TTh significantly counteracted HFD-induced inflammation, as detected in terms of expression of inflammatory markers and microglial activation. Moreover, TTh remarkably reverted the HFD-associated alterations in the expression of important regulators of energy status and reproduction, such as the melanocortin and the GnRH-controlling network. Our results suggest that TTh may exert neuroprotective effects on the HFD-related hypothalamic alterations, with positive outcomes on the circuits implicated in the control of energy metabolism and reproductive tasks, thus supporting a possible role of TTh in the clinical management of MetS.     

Identification of the Role of TGR5 in the Regulation of Leydig Cell Homeostasis

Understanding the regulation of the testicular endocrine function leading to testosterone production is a major objective as the alteration of endocrine function is associated with the development of many diseases such as infertility. In the last decades, it has been demonstrated that several endogenous molecules regulate the steroidogenic pathway. Among them, bile acids have recently emerged as local regulators of testicular physiology and particularly endocrine function. Bile acids act through the nuclear receptor FXRα (Farnesoid-X-receptor alpha; NR1H4) and the G-protein-coupled bile acid receptor (GPBAR-1; TGR5). While FXRα has been demonstrated to regulate testosterone synthesis within Leydig cells, no data are available regarding TGR5. Here, we investigated the potential role of TGR5 within Leydig cells using cell culture approaches combined with pharmacological exposure to the TGR5 agonist INT-777. The data show that activation of TGR5 results in a decrease in testosterone levels. TGR5 acts through the PKA pathway to regulate steroidogenesis. In addition, our data show that TGR5 activation leads to an increase in cholesterol ester levels. This suggests that altered lipid homeostasis may be a mechanism explaining the TGR5-induced decrease in testosterone levels. In conclusion, the present work highlights the impact of the TGR5 signaling pathway on testosterone production and reinforces the links between bile acid signaling pathways and the testicular endocrine function. The testicular bile acid pathways need to be further explored to increase our knowledge of pathologies associated with impaired testicular endocrine function, such as fertility disorders.     

Cryptorchism, hypogonadism and antler malformations in black-tailed deer(Odocoileus hemionus sitkensis) of Kodiak island

Summary Distinct antler malformations, (such as lack of points, distortion of antler forms, incomplete velvet shedding, casting above the coronet and a diagonal separation of cast antlers), were detected in Sitka deer(Odocoileus hemionus sitkensis) of the Kodiak Island (Alaska, USA). Many of these deer were also unilateral or bilateral cryptorchids and a few exhibited a moderate or severe separation of frontal skull bones. Radioimmunoassay analyses of serum revealed signs of hypogonadism: we found higher concentrations of LH (P=0.05) and lower concentrations of T (P=0.037) in bilateral cryptorchids as compared to intact bucks. There was no apparent impairment of spermatogenesis in the remaining testis of the unilateral cryptorchid deer. Unfortunately, no ectopic testes were so far recovered in cryptorchid deer. Surprisingly, only about half of deer with bilateral cryptorchism exhibited hypogonadic symptoms. In the other half of cryptorchid deer, the antlers appeared completely normal and the concentrations of LH or testosterone in the serum of several bucks were in the range of intact deer. It has been postulated that in some cryptorchid deer, ectopic testes can produce sufficient amount of testosterone, which prevents obvious antler and skull malformations, as well as reduces the compensatory elevation of LH. The possible causes of the hypogonadism resulting in cryptorchism and antler malformations are discussed.Eingesetzt wurde ein Druckkostenzuschuss des Hessischen Ministeriums für Umwelt, Landwirtschaft und Forsten, für dessen Gewährung verbindlich gedankt wird. — Die Schriftleitung     

The Role of Testosterone in the Elderly: What Do We Know?

Testosterone is the most important hormone in male health. Aging is characterized by testosterone deficiency due to decreasing testosterone levels associated with low testicular production, genetic factors, adiposity, and illness. Low testosterone levels in men are associated with sexual dysfunction (low sexual desire, erectile dysfunction), reduced skeletal muscle mass and strength, decreased bone mineral density, increased cardiovascular risk and alterations of the glycometabolic profile. Testosterone replacement therapy (TRT) shows several therapeutic effects while maintaining a good safety profile in hypogonadal men. TRT restores normal levels of serum testosterone in men, increasing libido and energy level and producing beneficial effects on bone density, strength and muscle as well as yielding cardioprotective effects. Nevertheless, TRT could be contraindicated in men with untreated prostate cancer, although poor findings are reported in the literature. In addition, different potential side effects, such as polycythemia, cardiac events and obstructive sleep apnea, should be monitored. The aim of our review is to provide an updated background regarding the pros and cons of TRT, evaluating its role and its clinical applicability in different domains.     

Plasma Metabolomics Profile of “Insulin Sensitive” Male Hypogonadism after Testosterone Replacement Therapy

Male hypogonadism is a disorder characterized by low levels of testosterone, but patients can either show normal insulin (insulin-sensitive (IS)) or over time they can become insulin-resistant (IR). Since the two groups showed different altered metabolisms, testosterone replacement therapy (TRT) could achieve different results. In this paper, we analyzed plasma from 20 IS patients with low testosterone (<8 nmol/L) and HOMAi < 2.5. The samples, pre- and post-treatment with testosterone for 60 days, were analyzed by UHPLC and mass spectrometry. Glycolysis was significantly upregulated, suggesting an improved glucose utilization. Conversely, the pentose phosphate pathway was reduced, while the Krebs cycle was not used. Branched amino acids and carnosine metabolism were positively influenced, while β-oxidation of fatty acids (FFA) was not activated. Cholesterol, HDL, and lipid metabolism did not show any improvements at 60 days but did so later in the experimental period. Finally, both malate and glycerol shuttle were reduced. As a result, both NADH and ATP were significantly lower. Interestingly, a significant production of lactate was observed, which induced the activation of the Cori cycle between the liver and muscles, which became the main source of energy for these patients without involving alanine. Thus, the treatment must be integrated with chemicals which are not restored in order to reactivate energy production.     

糖-蛋白质饮料对男力量运动员一次抗阻运动后部分血清指标的影响

为探讨糖-蛋白质补充对一次性抗阻运动恢复过程的影响.文中以18名男子力量项目运动员在一次抗阻运动前、运动中和运动后,分别摄入糖-高蛋白饮料(HP组=6人,糖:蛋白质=3∶1)、糖-低蛋白饮料(LP组=6人,糖∶蛋白质=6∶1)或纯糖对照饮料(C组=6人).在运动前、运动后即刻、运动后3h和运动后次日晨采集血样,测定血清肌酸激酶(CK)、天门冬氨酸转移酶(AST)、谷丙氨酸转移酶(ALT)、尿素(BU)以及睾酮(T)和皮质醇(Cor).研究结果表明:运动后3h和运动后次日晨C组CK水平显非常著高于HP组和LP组(P0.01,分别),运动后次日晨LP组CK水平显著高于HP组(P0.05);运动后3hC组ALT水平显著高于HP组和LP组(P0.05,分别);运动后即刻C组Cor水平显著低于HP组和LP组(P0.05,分别);各时间点T、AST及BU水平组间比较无差异性.摄入糖-蛋白质饮料能促进男性力量项目运动员抗阻运动后机体运动能力的恢复和提高.摄入糖-高比例蛋白质更有利于运动后疲劳的恢复和机体运动能力的提高.